Iotrolan

For research use only. Not for therapeutic Use.

  • CAT Number: I029448
  • CAS Number: 79770-24-4
  • Molecular Formula: C37H48I6N6O18
  • Molecular Weight: 1626.2418
  • Purity: 98%
Inquiry Now

Iotrolan(Cat NI029448) is a nonionic and isotonic contrast medium specifically formulated for intrathecal administration. It is used in medical imaging procedures, such as myelography and computed tomography (CT) scans, to enhance the visibility of the spinal cord and surrounding structures. As an intrathecal contrast agent, Iotrolan is injected into the cerebrospinal fluid space to provide improved visualization during diagnostic examinations. Its nonionic and isotonic properties help minimize the risk of adverse reactions and maintain the physiological balance of the fluid environment in the spinal canal.


Catalog Number I029448
CAS Number 79770-24-4
Synonyms

Iotrolan; DL 3-117; DL-3117; DL3-117; ZK 39 482; ZK 39482

Molecular Formula C37H48I6N6O18
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name 1,3-Benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-
InChI InChI=1S/C37H48I6N6O18/c1-48(32-28(40)22(34(64)44-12(4-50)16(58)8-54)26(38)23(29(32)41)35(65)45-13(5-51)17(59)9-55)20(62)3-21(63)49(2)33-30(42)24(36(66)46-14(6-52)18(60)10-56)27(39)25(31(33)43)37(67)47-15(7-53)19(61)11-57/h12-19,50-61H,3-11H2,1-2H3,(H,44,64)(H,45,65)(H,46,66)(H,47,67)
InChIKey XUHXFSYUBXNTHU-UHFFFAOYSA-N
SMILES O=C(N(C1=C(I)C(C(NC(CO)C(O)CO)=O)=C(I)C(C(NC(CO)C(O)CO)=O)=C1I)C)CC(N(C2=C(I)C(C(NC(CO)C(O)CO)=O)=C(I)C(C(NC(CO)C(O)CO)=O)=C2I)C)=O
Reference

1: Lenhard DC, May E, Morgenroth C, Jost G, Haider W, Pietsch H. Adverse skin reactions to iodinated x-ray contrast agents in healthy rats. Invest Radiol. 2014 Dec;49(12):779-87. doi: 10.1097/RLI.0000000000000084. PubMed PMID: 24988006.
2: Sovak M, Ranganathan R, Speck U. Nonionic dimer: development and initial testing of an intrathecal contrast agent. Radiology. 1982 Jan;142(1):115-8. PubMed PMID: 6895557.
3: Iwasaki K, Sudo H, Yamada K, Ito M, Iwasaki N. Cytotoxic effects of the radiocontrast agent iotrolan and anesthetic agents bupivacaine and lidocaine in three-dimensional cultures of human intervertebral disc nucleus pulposus cells: identification of the apoptotic pathways. PLoS One. 2014 Mar 18;9(3):e92442. doi: 10.1371/journal.pone.0092442. eCollection 2014. PubMed PMID: 24642945; PubMed Central PMCID: PMC3958541.
4: Krause W, Bunte T, Schubert R, Blaszkiewicz P. The lack of immunogenicity of iotrolan. Invest Radiol. 1995 Sep;30(9):548-51. PubMed PMID: 8537213.
5: Goebel C, Hardt P, Doppl W, Temme H, Hackstein N, Klör HU. Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. Eur Radiol. 2000;10(4):677-80. PubMed PMID: 10795554.
6: Miyazawa T, Nakagawa H. [Experimental evaluation of iotrolan as an arthrographic contrast medium–knee arthrography with iotrolan in rabbits]. Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Nov 25;50(11):1381-6. Japanese. PubMed PMID: 2087397.
7: Miyazawa T, Murayama C, Uchimoto R, Fritz-Zieroth B. [Preclinical evaluation of iotrolan as a contrast medium for angiography and urography]. Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Sep 25;52(9):1287-98. Japanese. PubMed PMID: 1437534.
8: Nauert C, Langer M, Mützel W. Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:40-5. PubMed PMID: 2568806.
9: Wenzel-Hora BI, Potthoff PC, Jänicke UA. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:148-52. PubMed PMID: 2568783.
10: Heinrich M, Schneider G, Grgic A, Humke U, Kramann B, Uder M. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol. Invest Radiol. 2004 Jul;39(7):406-12. PubMed PMID: 15194911.
11: Wagner A, Jensen C, Saebye A, Rasmussen TB. A prospective comparison of iotrolan and iohexol in lumbar myelography. Acta Radiol. 1994 Mar;35(2):182-5. PubMed PMID: 8172748.
12: Miyamoto Y, Tsujimoto T, Iwai K, Ishida K, Uchimoto R, Miyazawa T, Azuma H. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol. Invest Radiol. 1995 Sep;30(9):538-43. PubMed PMID: 8537211.
13: Dooley M, Jarvis B. Iomeprol: a review of its use as a contrast medium. Drugs. 2000 May;59(5):1169-86. Review. PubMed PMID: 10852647.
14: Peachell PT, Morcos SK. Effect of radiographic contrast media on histamine release from human mast cells and basophils. Br J Radiol. 1998 Jan;71(841):24-30. PubMed PMID: 9534695.
15: Mizuno J, Gauss T, Suzuki M, Hayashida M, Arita H, Hanaoka K. Encephalopathy and rhabdomyolysis induced by iotrolan during epiduroscopy. Can J Anaesth. 2007 Jan;54(1):49-53. PubMed PMID: 17197468.
16: Mezilis N, Salame MY, Dyet JF, Arafa SO, Oakley GD, Cumberland DC. Comparison of Iotrolan 320 and Iohexol 350 in cardiac angiography: a randomised double-blind clinical study. Eur J Radiol. 1998 Sep;28(2):171-5. PubMed PMID: 9788025.
17: Press WR, Mützel W, Schöbel C. Tolerance to iotrolan after subarachnoid injection in animals. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:126-33. PubMed PMID: 2568780.
18: Oldroyd SD, Fang L, Haylor JL, Yates MS, El Nahas AM, Morcos SK. Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney. Clin Sci (Lond). 2000 Mar;98(3):303-11. PubMed PMID: 10677389.
19: Morcos SK, Anderson PB, Baudouin SV, Clout C, Fairlie N, Baudouin C, Warnock N. Suitability of and tolerance to Iotrolan 300 in bronchography via the fibreoptic bronchoscope. Thorax. 1990 Aug;45(8):628-9. PubMed PMID: 2402728; PubMed Central PMCID: PMC462647.
20: van Bree H, Van Rijssen B, Van Ham L. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs. Am J Vet Res. 1991 Jun;52(6):926-33. PubMed PMID: 1883098.

Request a Quote